相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Trimodality Therapy for Malignant Pleural Mesothelioma
Gordon Buduhan et al.
ANNALS OF THORACIC SURGERY (2009)
Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study
C. Rake et al.
BRITISH JOURNAL OF CANCER (2009)
Is malignant pleural mesothelioma a surgical disease? A review of 83 consecutive extra-pleural pneumonectomies
Delphine Sophie Trousse et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2009)
Extrapleural pneumonectomy for malignant pleural mesothelioma: Outcomes of treatment and prognostic factors
Tristan D. Yan et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2009)
Prophylactic radiotherapy to intervention sites in mesothelioma: A systematic review and survey of UK practice
Caroline Lee et al.
LUNG CANCER (2009)
Asbestos-induced lung diseases: an update
David W. Kamp
TRANSLATIONAL RESEARCH (2009)
Management of malignant pleural effusions using the Pleurx catheter
William H. Warren et al.
ANNALS OF THORACIC SURGERY (2008)
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial
Martin F. Muers et al.
LANCET (2008)
Simian virus 40 and mesothelioma in Great Britain
Malcolm J. Price et al.
OCCUPATIONAL MEDICINE-OXFORD (2007)
Phase II study of erlotinib in patients with malignant pleural mesothelioma: A Southwest Oncology Group study
Linda L. Garland et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma
GL Ceresoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: the MED trial
MER O'Brien et al.
ANNALS OF ONCOLOGY (2006)
Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada
JP van Meerbeeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C Manegold et al.
ANNALS OF ONCOLOGY (2005)
Gefitinib in patients with malignant mesothelioma: A phase II study by the cancer and leukemia group B
R Govindan et al.
CLINICAL CANCER RESEARCH (2005)
Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma
NJ Vogelzang et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey
I Roushdy-Hammady et al.
LANCET (2001)
The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure
JT Hodgson et al.
ANNALS OF OCCUPATIONAL HYGIENE (2000)
Results of treatment of 33 patients with peritoneal mesothelioma
G Sebbag et al.
BRITISH JOURNAL OF SURGERY (2000)
分享论文
